Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate the Efficacy, Safety and Tolerability of Bermekimab in Patients With Hidradenitis Suppurativa

ClinicalTrials.gov ID: NCT04019041

Public ClinicalTrials.gov record NCT04019041. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 9:00 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Bermekimab in Patients With Moderate to Severe Hidradenitis Suppurativa

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study further evaluates the efficacy of bermekimab in treating moderate to severe hidradenitis suppurativa in adults. 1/3 of patients will receive weekly injections of bermekimab, 1/3 will receive alternating every other week injections of bermekimab or placebo, and 1/3 will receive weekly injections of placebo.

Study identification

NCT ID
NCT04019041
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
153 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 16, 2019 (Actual)
Primary completion
May 19, 2020 (Actual)
Completion
Nov 17, 2020 (Actual)
Last update posted
Jul 27, 2023

2019 – 2020

United States locations

U.S. sites
33
U.S. states
13
U.S. cities
28
Facility City State ZIP Site status
Desert Sky Gilbert Arizona 85295 —
Marvel Clinical Research Huntington Beach California 92647 —
University of Southern California Los Angeles California 90033 —
Dermatology Research Associates Los Angeles California 90045 —
Syrentis Clinical Research Santa Ana California 92705 —
Wolverine Clinical Trials Santa Ana California 92705 —
Visionary Investigators Network Aventura Florida 33180 —
Florida Academic Dermatology Centers Coral Gables Florida 33134 —
Doral Medical Research Doral Florida 33166 —
Floridian Research Institute Miami Florida 33145 —
Florida International Medical Research Miami Florida 33155 —
P&S Research, LLC Miami Florida 33175 —
Accel Clinical Research Orlando Florida 32819 —
Physica Clinical Research Sebastian Florida 32958 —
Avita Clinical Research Tampa Florida 33613 —
Forcare Clinical Research, Inc. Tampa Florida 33613 —
Integrated Clincal Research LLC West Palm Beach Florida 33406 —
Columbus Regional Research Institute Columbus Georgia 31904 —
Advanced Medical Research Sandy Springs Georgia 30328 —
Meridian Clinical Research, LLC Savannah Georgia 31406 —
Dawes Fretzin Clinical Research Group Indianapolis Indiana 46256 —
Randall Dermatology & Cosmetic Surgery West Lafayette Indiana 47906 —
Meridian Clinical Research, LLC Baton Rouge Louisiana 70808 —
Clinical Trials of SWLA Lake Charles Louisiana 70605 —
Oakland Hills Dermatology Auburn Hills Michigan 48326 —
Revival Research Institute, LLC Troy Michigan 48084 —
Washington University in St. Louis St Louis Missouri 63130 —
Icahn School of Medicine at Mount Sinai New York New York 10029 —
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 —
ClinOhio Research Services Columbus Ohio 43213 —
Clinical Research Solutions, LLC Milan Tennessee 38358 —
Progressive Clinical Research San Antonio Texas 78213 —
Dominion Medical Associates, Inc. Richmond Virginia 23233 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04019041, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 27, 2023 · Synced Nov 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04019041 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →